Velcade and hypotension Patient Reports February 11, 2012

Velcade Side Effects Report #5093281-5
Velcade side effect was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient, 66 years of age, weighting 105.8 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypotension, lung infection, neutropenia, platelet count decreased, pneumonia , tachycardia, vomiting. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/12/2006.

Velcade Side Effects Report #5126346-X
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Male patient, 66 years of age, weighting 105.8 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , blood count abnormal, diarrhoea, dyspnoea, hypotension, hypoxia, infection , neutropenia, platelet count decreased. Velcade dosage: 1.30MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/12/2006.

Velcade Side Effects Report #5592622-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 01, 2008. Male patient, 66 years of age, weighting 105.8 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , diarrhoea, hypotension, hypoxia, neutropenia, neutrophil count decreased, platelet count decreased, pneumonia , refusal of treatment by relative. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 08/12/2006.

Velcade Side Effects Report #5092382-5
Velcade side effect was reported by a Physician from UNITED STATES on Aug 14, 2006. Male patient, 62 years of age, weighting 165.3 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood pressure orthostatic decreased, diarrhoea, dizziness , granulocytes abnormal, hypotension, neutrophil count, white blood cell disorder. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5939517-7
Velcade side effect was reported by a Physician from UNITED STATES on Oct 20, 2008. Male patient, 53 years of age, weighting 231.5 lb, was diagnosed with renal cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoglycaemia, hypotension, syncope. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5601979-2
Velcade side effect was reported by a Physician from UNITED STATES on Jan 11, 2008. Female patient, 43 years of age, weighting 174.2 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, fatigue, hypermagnesaemia, hypomagnesaemia, hypotension, lethargy, muscular weakness. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with FLAVOPIRIDOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5149795-2
Velcade side effect was reported by a Physician from UNITED STATES on Oct 27, 2006. Male patient, 55 years of age, weighting 238.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood sodium decreased, body temperature decreased, cardio-respiratory arrest, hypotension, loss of consciousness, multi-organ failure, oxygen saturation decreased. Velcade dosage: 1 MG/M2, UNK, IV BOLUS. During the same period patient was treated with GEMCITABINE, ACETYLSALICYLIC AICD, DICYCLOMINE, LEVENOX, FELODIPINE, FENTANYL, FOLIC ACID, INSULIN. Patient was hospitalized. Patient died on 05/02/2003.

Velcade Side Effects Report #5930458-8
Velcade side effect was reported by a Physician from UNITED STATES on Oct 11, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , ascites, bacterial infection , dizziness , hypoalbuminaemia, hypotension, nausea , platelet count decreased. Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5951028-1
Velcade side effect was reported by a Physician from UNITED STATES on Oct 29, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , bacterial infection , disease progression, dizziness , hypoalbuminaemia, hypotension, nausea , pancreatic carcinoma, peritoneal infection. Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient died on 10/16/2008.


Velcade Side Effects Report #5989563-2
Velcade side effect was reported by a Physician from UNITED STATES on Nov 27, 2008. Female patient, 53 years of age, weighting 122.4 lb, was diagnosed with pancreatic carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , ascites, bacterial infection , disease progression, dizziness , hypoalbuminaemia, hypotension, multi-organ failure, nausea . Velcade dosage: 1.3 MG/M2, IV BOLUS. Patient was hospitalized. Patient died on 10/16/2008.

Velcade Side Effects Report #5320779-4
Velcade side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, 53 years of age, weighting 175.0 lb, was diagnosed with non-small cell lung cancer stage iiia and was treated with Velcade. After drug was administered, patient experienced the following side effects: acidosis, emphysema, empyema, haemoptysis, hypotension, impaired healing, pneumonia , post procedural complication. Velcade dosage: 1.00 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, PROTONIX, IBUPROFEN, ALBUTEROL, ATROVENT, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 03/28/2005.

Velcade Side Effects Report #5322094-1
Velcade side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, 53 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer stage iiia and was treated with Velcade. After drug was administered, patient experienced the following side effects: dizziness , hypotension, night sweats, no therapeutic response, radiation oesophagitis, radiation pneumonitis, tachycardia, viral infection . Velcade dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, PREVACID, ALLEGRA, TYLENOL W, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5958358-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , chronic obstructive pulmonary disease, fall , hypotension, pneumonia , pulmonary embolism , sepsis , thrombocytopenia, urinary tract infection . Velcade dosage: 2 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5989560-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: arteriosclerosis, atrial fibrillation , fall , hypotension, pleural effusion, pneumonia , pulmonary embolism , sepsis , thrombocytopenia. Velcade dosage: 2MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPRIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #6016927-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 11, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , chronic obstructive pulmonary disease, condition aggravated, fall , hypotension, lung infiltration, pleural effusion, pneumonia , pulmonary embolism . Velcade dosage: 2 MG/M2, INTRAVEOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4587474-0
Velcade side effect was reported by a Physician from on Jan 25, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, hypotension, neutropenia, pneumonia , productive cough, renal failure acute, respiratory failure. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 12/22/2004.

Velcade Side Effects Report #4769119-X
Velcade side effect was reported by a Pharmacist from UNITED STATES on May 19, 2005. Male patient, 57 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypotension. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5587721-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2007. Female patient, 74 years of age, weighting 144.8 lb, was diagnosed with neoplasm and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, brain oedema, bronchitis , chest pain , dehydration, dyspnoea, hypotension, metastases to central nervous system, muscular weakness. Velcade dosage: 2.40 MG,. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5453459-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 04, 2007. Male patient, 48 years of age, was diagnosed with neoplasm and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , atrial flutter, dizziness , fall , head injury, hypotension, syncope. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5220977-4
Velcade side effect was reported by a Physician from FRANCE on Jan 11, 2007. Male patient, 71 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, adhesion , bronchopulmonary aspergillosis, hilar lymphadenopathy, hypotension, ileus paralytic, intestinal obstruction, renal failure acute, respiratory disorder. Velcade dosage: 3.30 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 11/01/2006.

Velcade Side Effects Report #5165150-3
Velcade side effect was reported by a Physician from FRANCE on Nov 13, 2006. Male patient, 71 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, chest x-ray abnormal, condition aggravated, hilar lymphadenopathy, hypotension, ileus paralytic, intestinal obstruction, renal failure, respiratory disorder. Velcade dosage: 3.30 MG INTRAVENOUS. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient died on 11/01/2006.

Velcade Side Effects Report #5127196-0
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 82 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, atrial fibrillation , diastolic dysfunction, flank pain, hypotension, lung infiltration, pneumonia , pneumonitis. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with BETAPACE, ALTACE, ASPIRIN, NEURONTIN, ZOLOFT, FOLIC ACID, DARVOCET. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5169030-9
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Female patient, 82 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve disease, atrial fibrillation , blood potassium decreased, brain natriuretic peptide increased, cardiac failure congestive, dilatation atrial, hypotension, malignant hypertension, mitral valve incompetence. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with BETAPACE, ALTACE, ASPIRIN, NEURONTIN, ZOLOFT, FOLIC ACID, DARVOCET. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5717249-8
Velcade side effect was reported by a Physician from UNITED STATES on Apr 14, 2008. Male patient, 81 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, atrial fibrillation , atrial flutter, atrioventricular block, chest pain , heart rate increased, hypotension, platelet count decreased. Velcade dosage: 1.00 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, ACYCLOVIR, BACTRIUM DS, FERRO, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MYCELEX. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5226856-0
Velcade side effect was reported by a Physician from JAPAN on Jan 18, 2007. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood potassium decreased, condition aggravated, electrocardiogram qt prolonged, hypotension, no therapeutic response, pulmonary embolism , respiratory arrest, torsade de pointes, ventricular tachycardia. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with LAFUTIDINE, SELBEX, DIFLUCAN, ALENDRONATE, ROHYPNOL, BAKTAR, HEPARIN. Patient died on 01/08/2007.

Velcade Side Effects Report #5273285-X
Velcade side effect was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypokalaemia, hypotension, no therapeutic response, pulmonary artery thrombosis, pulmonary embolism , respiratory arrest, torsade de pointes. Velcade dosage: unknown. During the same period patient was treated with LAFUTIDINE, SELBEX, DIFLUCAN, ALENDRONATE, ROHYPNOL, BAKTAR, HEPARIN. Patient died on 01/08/2007.

Velcade Side Effects Report #5398442-3
Velcade side effect was reported by a Physician from JAPAN on July 11, 2007. Male patient, 80 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, atrophy, bone marrow failure, cardio-respiratory arrest, electrocardiogram qt prolonged, hypokalaemia, hypotension, immobile, nephrolithiasis. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with LAFUTIDINE, SELBEX, DIFLUCAN, ALENDRONATE, ROHYPNOL, SULFAMETHOXAZOLE, HEPARIN. Patient died on 01/08/2007.

Velcade Side Effects Report #5607511-1
Velcade side effect was reported by a Health Professional from UNITED STATES on Jan 21, 2008. Male patient, 80 years of age, weighting 160.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypotension, no therapeutic response. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748786-8
Velcade side effect was reported by a Physician from SPAIN on May 09, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, head injury, hypotension, loss of consciousness. Velcade dosage: 2.4 MG, INTRAVENOUS. During the same period patient was treated with ARANESP, CALCIUM SANDOZTE D, NEURONTIN, CASODEX, COZAAR PLUS, ALLOPURINOL, OMEPRAZOLE, FORTECORTIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #6026132-2
Velcade side effect was reported by a Physician from UNITED STATES on Dec 16, 2008. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood calcium decreased, blood sodium decreased, bone pain, cardiac failure congestive, ejection fraction decreased, haemoglobin decreased, hypotension, left ventricular dysfunction. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #6072789-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 27, 2009. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, asthenia, blood calcium decreased, blood sodium decreased, cardiac failure congestive, haemoglobin decreased, hypotension, left ventricular dysfunction, muscular weakness. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE, PERCOCET, LIPITOR, DIOVAN, ASPIRIN, LACTULOSE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #6140485-6
Velcade side effect was reported by a Physician from UNITED STATES on Mar 19, 2009. Male patient, 80 years of age, weighting 136.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood calcium decreased, blood sodium decreased, cardiac failure congestive, haemoglobin decreased, hypotension, left ventricular dysfunction, muscular weakness, musculoskeletal pain. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, OXYCODONE, PERCOCET, LIPITOR, DIOVAN, ASPIRIN, LACTULOSE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5786117-8
Velcade side effect was reported by a Health Professional from FRANCE on June 12, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, aplasia, bradycardia, hypotension, hypoxia, sepsis , shock. Velcade dosage: 2.1 MG, INTRAVENOUS. During the same period patient was treated with ONDANSETRON, OSTRAM, KARDEGIC, BISOPROLOL FUMARATE, COZAAR, FOSAMAX, ACETAMINOPHEN. Patient died on 05/14/2008.

Velcade Side Effects Report #5798850-2
Velcade side effect was reported by a Health Professional from FRANCE on June 19, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, aplasia, atrial fibrillation , bradycardia, cardiac failure, hypotension, multi-organ failure, respiratory distress, sepsis . Velcade dosage: 2.1 MG, INTRAVENOUS. During the same period patient was treated with ONDANSETRON, OSTRAM, KARDEGIC, BISOPROLOL FUMARATE, COZAAR, FOSAMAX, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/14/2008.


Velcade Side Effects Report #5384677-2
Velcade side effect was reported by a Physician from UNITED STATES on May 11, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, hypotension, renal failure acute, respiratory failure, skin lesion. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE, COUMADIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4711309-6
Velcade side effect was reported by a Physician from UNITED STATES on June 23, 2005. Female patient, 78 years of age, weighting 151.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , cardiac failure congestive, catheter site infection, clostridium colitis, dehydration, hypotension, laryngeal disorder, lung infection. Velcade dosage: 7.02 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient died on 06/01/2005.

Velcade Side Effects Report #5534371-X
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 77 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis, platelet count decreased and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , erythema multiforme, hypotension, lymphopenia, platelet count decreased, viral infection . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, BAKTAR, PLATELETS, DEXAMETHASONE, ALLOPURINOL, ZANTAC, MUCOSTA, LASIX. Patient recovered.

Velcade Side Effects Report #5602195-0
Velcade side effect was reported by a Physician from JAPAN on Jan 10, 2008. Male patient, 77 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis, platelet count decreased and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , erythema multiforme, hiccups, hypoaesthesia, hypotension, lymphopenia, platelet count decreased, upper respiratory tract inflammation, viral infection . Velcade dosage: 2.00 MG, INTRAVENOUS; 1.60 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, BAKTAR, PLATELETS, DEXAMETHASONE, ALLOPURINOL, ZANTAC, MUCOSTA. Patient recovered.

Velcade Side Effects Report #4769127-9
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on June 03, 2005. Female patient, 76 years of age, weighting 177.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, asthenia, bone pain, dehydration, dyspnoea, fatigue, hypotension, insomnia. Velcade dosage: unknown. During the same period patient was treated with FENTANYL, ACIPHEX, NASAREL, BACTRIM DS, SINGULAIR, ATENOLOL, PREMARIN. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5236465-5
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 30, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, haemodialysis, hypotension, renal failure, renal tubular necrosis, sepsis , staphylococcal infection , tumour lysis syndrome. Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PAMIDRONATE DI, SULFAMETHOXAZOLE, ALLOPURINOL, PROPRANOLOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5288283-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on Mar 21, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood culture positive, haemodialysis, hypotension, renal failure, renal tubular necrosis, sepsis , staphylococcal infection , tumour lysis syndrome. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PAMIDRONATE DI, SULFAMETHOXAZOLE, ALLOPURINOL, PROPRANOLOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5291322-3
Velcade side effect was reported by a Physician from ITALY on Mar 27, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute prerenal failure, anaemia, bradycardia, electrocardiogram qt prolonged, electrocardiogram t wave inversion, hypokalaemia, hypotension, nausea . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, MELPHALAN, PREDNISONE, ALLOPURINOL, ACYCLOVIR, CIPROFLOXACIN, LAMIVUDINE, PLASIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5074769-X
Velcade side effect was reported by a Physician from FRANCE on July 24, 2006. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: accidental overdose, candida sepsis, cardiac failure, dialysis , escherichia sepsis, hypotension, incorrect dose administered, lactic acidosis. Velcade dosage: 2.40 MG. Patient was hospitalized. Patient died on 04/14/2006.

Velcade Side Effects Report #5148537-4
Velcade side effect was reported by a Physician from UNITED KINGDOM on Oct 29, 2006. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypotension, renal failure, sepsis . Velcade dosage: 1.30 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with MELPHALAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5453458-3
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dizziness postural, fatigue, hypophosphataemia, hypotension, lethargy, malaise, orthostatic hypotension, thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. During the same period patient was treated with ANZEMET, AVELOX, ENALAPRIL MALEATE, FAMVIR, FLOMAX, FLUCONAZOLE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5694198-5
Velcade side effect was reported by a Physician from JAPAN on Mar 24, 2008. Male patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, anorectal disorder, bladder disorder, hypotension, intestinal functional disorder, malaise, micturition disorder. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with MAGNESIUM OXIDE, SENNA, HEPARIN, DEXAMETHASONE PHOSPHATE, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE, ZOLPIDEM TARTRATE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5908992-6
Velcade side effect was reported by a Physician from SPAIN on Sept 22, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , disease progression, hypotension, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5917452-8
Velcade side effect was reported by a Physician from SPAIN on Sept 29, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, disease progression, hypotension, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5933718-X
Velcade side effect was reported by a Physician from SPAIN on Oct 15, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, disease progression, hypotension, no therapeutic response, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE, DIGOXIN, VALSARTAN, VERAPAMIL. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #6050733-9
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, capillary leak syndrome, constipation , hyperphosphatasaemia, hyponatraemia, hypotension, non-cardiogenic pulmonary oedema. Velcade dosage: 1.8 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE, DOPAMINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4758421-3
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Aug 12, 2005. Female patient, 73 years of age, weighting 117.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: autonomic neuropathy, hypotension, intestinal functional disorder, rash , urinary retention. Velcade dosage: 2.00 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4838218-6
Velcade side effect was reported by a Physician from GERMANY on Nov 11, 2005. Female patient, 73 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disturbance in attention, hyponatraemia, hypotension, nausea , syncope, vertigo. Velcade dosage: 2.60 MG, UNK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, COTRIMTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4998644-1
Velcade side effect was reported by a Physician from FRANCE on Apr 27, 2006. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: accidental overdose, candidiasis, escherichia infection, hypotension, lactic acidosis, myocarditis, pulmonary alveolar haemorrhage. Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient died on 04/14/2006.

Velcade Side Effects Report #5030931-3
Velcade side effect was reported by a Physician from FRANCE on June 06, 2006. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: accidental overdose, candidiasis, cardiac failure, dialysis , escherichia infection, hypotension, lactic acidosis, myocarditis. Velcade dosage: 2.60 MG/M2. Patient was hospitalized. Patient died on 04/14/2006.

Velcade Side Effects Report #5610933-6
Velcade side effect was reported by a Physician from UNITED STATES on Jan 21, 2008. Male patient, 72 years of age, weighting 189.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: convulsion, fatigue, hypotension, unresponsive to stimuli. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, INSULIN, HYZAAR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5616265-4
Velcade side effect was reported by a Physician from UNITED STATES on Jan 25, 2008. Male patient, 72 years of age, weighting 189.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: convulsion, fatigue, hypotension, unresponsive to stimuli. Velcade dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, INSULIN, HYZAAR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4804363-4
Velcade side effect was reported by a Physician from UNITED STATES on Sept 29, 2005. Male patient, 72 years of age, weighting 252.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ankle fracture, asthenia, autonomic neuropathy, blood creatinine increased, blood urea increased, fall , hypotension, joint sprain, mitral valve incompetence. Velcade dosage: 4.00 MG, INTRAVENOUS. During the same period patient was treated with GANTOVAN, ACTOS, LOTREL, CRESTOR, COMPAZINE, LORTAB, INSULIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4878071-8
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Dec 26, 2005. Male patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase increased, blood albumin decreased, condition aggravated, haemodialysis, haemoglobin abnormal, hypotension, labile blood pressure, platelet disorder. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient died on 08/01/2003.

Velcade Side Effects Report #5353547-8
Velcade side effect was reported by a Physician from JAPAN on June 01, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood potassium decreased, blood urea increased, blood uric acid increased, c-reactive protein increased, hypotension, lymphopenia. Velcade dosage: 2.00 MG. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, GANATON, DEPAS, NOVAMIN, GOSHAJINKIGAN, SULFAMETHOXAZOLE. Patient died on 05/31/2007.


Velcade Side Effects Report #5451071-5
Velcade side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, cardiac failure, hypotension, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5458047-2
Velcade side effect was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: folliculitis, hypotension, nasopharyngitis, neutrophil count decreased, oral herpes, platelet count decreased, pyrexia, toxic skin eruption, white blood cell count decreased. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with RANTIDINE HYDROCHLORIDE, REBAMIPIDE, PANTETHINE, MAGNESIUM OXIDE, PAROXETINE, AMOXICILLIN W, KAKKON. Patient recovered.

Velcade Side Effects Report #5489257-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 05, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, enteritis, enterococcal infection, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5491279-6
Velcade side effect was reported by a Physician from JAPAN on Oct 05, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood potassium decreased, blood urea increased, blood uric acid increased, c-reactive protein increased, hypotension, lymphopenia. Velcade dosage: 2.00 MG,. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, GANATON, DEPAS, NOVAMIN, GOSHAJINKIGAN, BAKTAR. Patient died on 05/31/2007.

Velcade Side Effects Report #5517833-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, diarrhoea, enteritis, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2 ; 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5911538-X
Velcade side effect was reported by a Physician from UNITED STATES on Sept 22, 2008. Male patient, 71 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: accidental overdose, dyspnoea, hypotension. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, VANCOMYCIN, VERSED, METOPROLOL TARTRATE, HEPARIN, FENTANYL, NEXIUM, ATORVASTATIN CALCIUM. Patient recovered.

Velcade Side Effects Report #4881252-0
Velcade side effect was reported by a Physician from UNITED STATES on Oct 17, 2005. Male patient, 71 years of age, weighting 134.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , clostridial infection, dehydration, hyponatraemia, hypotension, nausea . Velcade dosage: 4.60 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5215331-5
Velcade side effect was reported by a Physician from JAPAN on Jan 05, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood calcium decreased, gastrointestinal haemorrhage, haemorrhagic diathesis, hypotension, mouth haemorrhage, multiple myeloma , pancytopenia, purpura. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, NEUPOGEN. Patient died on 12/26/2006.

Velcade Side Effects Report #5451074-0
Velcade side effect was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5477532-0
Velcade side effect was reported by a Physician from JAPAN on Sept 21, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, disease progression, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG UNK INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.


Velcade Side Effects Report #5484425-1
Velcade side effect was reported by a Physician from JAPAN on Oct 01, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, disease progression, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5768152-9
Velcade side effect was reported by a Physician from GREECE on May 28, 2008. Male patient, 68 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: herpes zoster, hypotension, infection , thrombocytopenia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS; 1.1 MG/M2. During the same period patient was treated with DEXAMETHASONE, ACETYLSALICYLIC ACID SRT, TELMISARTAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4944118-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Feb 21, 2006. Male patient, 68 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: ankle fracture, disease progression, fall , hypotension, sinus bradycardia, syncope. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with CYMBALTA, LISINOPRIL, FOLIC ACID, VITAMINS, CALCIUM GLUCONATE, VITAMIN B CAP, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4957047-6
Velcade side effect was reported by a Physician from UNITED STATES on Mar 08, 2006. Female patient, 68 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dizziness , fall , hyponatraemia, hypotension, injury, loss of consciousness. Velcade dosage: unknown. During the same period patient was treated with PREDNISONE, CELEXA, LEVOXYL, FLUDROCORTISONE ACETATE. Patient recovered.

Velcade Side Effects Report #5608222-9
Velcade side effect was reported by a Physician from JAPAN on Jan 17, 2008. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , hypokalaemia, hyponatraemia, hypotension, loss of consciousness, platelet count decreased, pyrexia, white blood cell count decreased. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ENTECAVIR HYDRATE, FAMOTIDINE, MAGNESIUM OXIDE, NEUTROGIN, BAKTAR, DIFLUCAN, ZOMETA. Patient recovered.

Velcade Side Effects Report #5641667-X
Velcade side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , hypokalaemia, hyponatraemia, hypotension, loss of consciousness, platelet count decreased, pyrexia, white blood cell count decreased. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ENTECAVIR HYDRATE, FAMOTIDINE, MAGNESIUM OXIDE, NEUTROGIN, BAKTAR, DIFLUCAN, ZOMETA. Patient recovered.

Velcade Side Effects Report #5768563-1
Velcade side effect was reported by a Physician from JAPAN on May 30, 2008. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , hypokalaemia, hyponatraemia, hypotension, loss of consciousness, platelet count decreased, pyrexia, white blood cell count decreased. Velcade dosage: 1.80 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ENTECAVIR HYDRATE, GASTER, MAGNESIUM OXIDE, NEUTROGIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIFLUCAN, ZOMETA. Patient recovered.

Velcade Side Effects Report #5856073-2
Velcade side effect was reported by a Physician from SINGAPORE on Aug 11, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypotension, pyrexia, renal failure acute, rhabdomyolysis, sepsis . Velcade dosage: 1.3MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMTHASONE, FLUCONAZOLE, ACYCLOVIR, ACETYLSALICYLIC ACID. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5203932-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 27, 2006. Male patient, 66 years of age, weighting 192.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: calcinosis, dyspnoea, electrocardiogram st-t change, hyperhidrosis, hypertrophic cardiomyopathy, hypotension, lung neoplasm, sepsis , stem cell transplant. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5248602-7
Velcade side effect was reported by a Physician from AUSTRALIA on Feb 12, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypotension, hypoxia, lung injury, pyrexia, tachycardia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient died.


Velcade Side Effects Report #5348596-X
Velcade side effect was reported by a Physician from UNITED STATES on May 24, 2007. Male patient, 66 years of age, weighting 192.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dyspnoea, hyperhidrosis, hypertrophic cardiomyopathy, hypotension, syncope. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5472658-X
Velcade side effect was reported by a Physician from AUSTRALIA on Feb 16, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypotension, hypoxia, lung injury, pyrexia, tachycardia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient died.

Velcade Side Effects Report #5472678-5
Velcade side effect was reported by a Physician from AUSTRALIA on Feb 16, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, herpes zoster, hypotension, influenza, pneumonia , pneumonitis, pulmonary toxicity, respiratory failure. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, ADRIAMYCIN PFS, BACTRIM, NEXIUM, AMITRIPTYLINE, SIMVASTATIN, NYSTATIN, VALACYCLOVIR. Patient was hospitalized. Patient died on 06/25/2006.

Velcade Side Effects Report #5483163-9
Velcade side effect was reported by a Physician from AUSTRALIA on Sept 28, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchiolitis, herpes zoster, hypotension, influenza, pneumonia , pneumonitis, pulmonary toxicity, respiratory failure, tachycardia. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with DEXAMETHASONE, ADRIAMYCIN PFS, BACTRIM, NEXIUM, AMITRIPTYLINE, SIMVASTATIN, NYSTATIN, VALACYCLOVIR. Patient was hospitalized. Patient died on 06/25/2006.

Velcade Side Effects Report #5578223-8
Velcade side effect was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, condition aggravated, disease progression, hypotension, nausea . Velcade dosage: 2.20 MG. During the same period patient was treated with ULCERLMIN, DEXAMETHASONE, DIGOXIN, VOLTAREN, MAGNESIUM OXIDE, CYTOTEC, PURSENNID, LANSOPRAZOLE. Patient was hospitalized. Patient died on 06/11/2007.

Velcade Side Effects Report #5615694-2
Velcade side effect was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood alkaline phosphatase increased, blood urea increased, disease progression, hypotension, nausea , platelet count decreased, pneumonia . Velcade dosage: 2.20 MG,. During the same period patient was treated with DEXAMETHASONE, DIGOXIN, VOLTAREN, MAGNESIUM OXIDE, CYTOTEC, PURSENNID, LANSOPRAZOLE, AMITRIPTYLINE. Patient was hospitalized. Patient died on 06/11/2007.

Velcade Side Effects Report #5725766-X
Velcade side effect was reported by a Physician from UNITED STATES on Apr 16, 2008. Male patient, 66 years of age, weighting 245.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cellulitis , hypotension. Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MELPHALAN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5281189-1
Velcade side effect was reported by a Physician from SPAIN on Mar 16, 2007. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemodynamic instability, hypotension, ileus paralytic. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient recovered.

Velcade Side Effects Report #5074271-5
Velcade side effect was reported by a Physician from ITALY on July 21, 2006. Female patient, 65 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dermatitis, hypotension, oedema peripheral. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5122648-1
Velcade side effect was reported by a Physician from BRAZIL on Sept 22, 2006. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, cough, fatigue, haemoglobin decreased, haemoptysis, hypotension, malaise, muscle spasms, myocardial infarction. Velcade dosage: 1.30 MG/M2. Patient died on 09/21/2006.

Velcade Side Effects Report #5485963-8
Velcade side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 27, 2007. Male patient, 65 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: catheter sepsis, cerebellar infarction, dyspnoea, hypotension, pneumonia , reversible posterior leukoencephalopathy syndrome. Velcade dosage: 2.30 MG,. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, VINCRISTINE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5940391-3
Velcade side effect was reported by a Physician from SPAIN on Oct 20, 2008. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemodynamic instability, hypotension, ileus paralytic. Velcade dosage: 2.3 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient recovered.

Velcade Side Effects Report #4865813-0
Velcade side effect was reported by a Physician from GERMANY on Dec 05, 2005. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , hypotension, syncope. Velcade dosage: 2.40 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5244231-X
Velcade side effect was reported by a Physician from SPAIN on Feb 01, 2007. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hypotension, pleural effusion, pneumonia , renal failure, right ventricular failure, somnolence. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5255394-4
Velcade side effect was reported by a Physician from SPAIN on Feb 16, 2007. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac disorder, cytolytic hepatitis, hypotension, pleural effusion, pneumonia , renal failure, somnolence. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5054161-4
Velcade side effect was reported by a Physician from POLAND on June 26, 2006. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, dehydration, erythema multiforme, fatigue, fluid intake reduced, herpes zoster, hyponatraemia, hypotension, nausea . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, FUROSEMIDE, ALLOPURINOL, SIMVASTATIN, CODEINE, CETIRIZINE, LOPERAMIDE, TORECAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4859824-9
Velcade side effect was reported by a Physician from POLAND on Nov 30, 2005. Male patient, 64 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, hypotension, palmar-plantar erythrodysaesthesia syndrome, syncope. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4865686-6
Velcade side effect was reported by a Physician from UNITED STATES on Dec 05, 2005. Male patient, 64 years of age, weighting 231.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina unstable, aortic arteriosclerosis, atelectasis, cardiac disorder, coronary artery occlusion, coronary artery stenosis, ejection fraction decreased, hypotension, scar . Velcade dosage: 1.60 MG/M2, INTRAVENOUS. During the same period patient was treated with FLEXERIL, COMPAZINE, ZOVIRAX, VALTREX, LORCET, NEURONTIN, LIDODERM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4881270-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2005. Male patient, 64 years of age, weighting 212.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypotension, ileus. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, HYDROCHLOROTHIAZIDE, ASPIRIN, PERCOCET, ATIVAN, DECADRON PHOSPHATE, COMPAZINE, VITAMIN B6. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4891917-2
Velcade side effect was reported by a Physician from GERMANY on Jan 09, 2006. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , hypotension, syncope. Velcade dosage: 2.40 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #4916470-6
Velcade side effect was reported by a Physician from GERMANY on Jan 30, 2006. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , headache , hypotension, loss of consciousness, syncope, vertigo. Velcade dosage: 2.40 MG, INTRAVENOUS. Patient recovered.